BamSEC and AlphaSense Join Forces
Learn More

Context Therapeutics Inc. – Indentures

NASDAQ: CNTX    
Share price (7/8/26): $0.60    
Market cap (7/8/26): $54.7 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 3 pages Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3 47 pages Context Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Context Therapeutics Inc
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3 43 pages Context Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.1
from 10-Q 15 pages Common Stock Purchase Warrant Context Therapeutics Inc
12/34/56
EX-4.1
from 10-Q 18 pages Common Stock Purchase Warrant Context Therapeutics Inc
12/34/56
EX-4.4
from S-1 22 pages Voting Agreement
12/34/56
EX-4.3
from S-1 17 pages Right of First Refusal and Co-Sale Agreement
12/34/56
EX-4.2
from S-1 24 pages Investors’ Rights Agreement
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56
EX-4.4
from DRS/A 22 pages Voting Agreement
12/34/56
EX-4.3
from DRS/A 17 pages Right of First Refusal and Co-Sale Agreement
12/34/56
EX-4.2
from DRS/A 24 pages Investors’ Rights Agreement
12/34/56